These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21388828)

  • 1. Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
    Sprigg N; Gray LJ; Bath PM; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):587-93. PubMed ID: 21388828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
    Gray LJ; Sprigg N; Bath PM; Boysen G; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    Stroke; 2007 Nov; 38(11):2960-4. PubMed ID: 17901387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
    Gray LJ; Sprigg N; Bath PM; Sørensen P; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein B; van der Sande JJ; Turpie AG;
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):327-33. PubMed ID: 16046439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Neurol Sci; 2007 Mar; 254(1-2):54-9. PubMed ID: 17258770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
    Bath PM; Lindenstrom E; Boysen G; De Deyn P; Friis P; Leys D; Marttila R; Olsson J; O'Neill D; Orgogozo J; Ringelstein B; van der Sande J; Turpie AG
    Lancet; 2001 Sep; 358(9283):702-10. PubMed ID: 11551576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial.
    Sprigg N; Gray LJ; Bath PM; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein B; van der Sande JJ; Lindenstrøm E;
    J Hypertens; 2006 Jul; 24(7):1413-7. PubMed ID: 16794492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
    England TJ; Bath PM; Sare GM; Geeganage C; Moulin T; O'Neill D; Woimant F; Christensen H; De Deyn P; Leys D; Ringelstein EB;
    Stroke; 2010 Dec; 41(12):2834-9. PubMed ID: 21030711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Stroke Cerebrovasc Dis; 2007; 16(4):180-4. PubMed ID: 17689415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
    Sare GM; Bath PM; Gray LJ; Moulin T; Woimant F; England T; Geeganage C; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    Stroke; 2009 Jan; 40(1):41-6. PubMed ID: 18988907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of acute ischemic stroke care in Thailand: a prospective multicenter countrywide cohort study.
    Nilanont Y; Nidhinandana S; Suwanwela NC; Hanchaiphiboolkul S; Pimpak T; Tatsanavivat P; Saposnik G; Poungvarin N;
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):213-9. PubMed ID: 23305673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Kumagai N; Origasa H; Nagao T; Takekawa H; Okuhara Y; Yamaguchi T
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):792-8. PubMed ID: 22633681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?
    Farquhar D
    CMAJ; 2001 Feb; 164(3):396. PubMed ID: 11232150
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
    de Ridder I; den Hertog H; van Gemert M; Dippel D; van der Worp B;
    Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial.
    Barrett KM; Brott TG; Brown RD; Carter RE; Geske JR; Graff-Radford NR; McNeil RB; Meschia JF;
    J Stroke Cerebrovasc Dis; 2011; 20(3):177-82. PubMed ID: 21295494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distance from home to hospital and thrombolytic utilization for acute ischemic stroke.
    Acharya AB; Nyirenda JC; Higgs GB; Bloomfield MS; Cruz-Flores S; Connor LT; Lee JM; Leet TL
    J Stroke Cerebrovasc Dis; 2011; 20(4):295-301. PubMed ID: 20634096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.